PAVM - PAVmed Inc.

0.6015
0.002   0.249%

Share volume: 447,366
Last Updated: 04-08-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$0.60
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
26%
Profitability 43%
Dept financing 29%
Liquidity 22%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.09%
1 Month
-8.86%
3 Months
-1.02%
6 Months
-51.88%
1 Year
-71.36%
2 Year
-89.63%
Key data
Stock price
$0.60
P/E Ratio 
0.22
DAY RANGE
$0.58 - $0.68
EPS 
-$4.68
52 WEEK RANGE
$0.55 - $2.43
52 WEEK CHANGE
-$70.94
MARKET CAP 
6.946 M
YIELD 
N/A
SHARES OUTSTANDING 
10.406 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
BETA 
1.25
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$198,663
AVERAGE 30 VOLUME 
$166,607
Company detail
CEO: Lishan Aklog
Region: US
Website: pavmed.com
Employees: 90
IPO year: 2016
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE)

Recent news
loading